Lupin bags USFDA tentative approval for Dasatinib Tablets; stock jumps ~2%
Dasatinib Tablets (RLD Sprycel) has expected annual sales in the United States of USD 1,569 million, as per the IQVIA MAT June 2022.
United States Pharmascience Inc Lupin Limited Bristol Myers Squibb Company Sprycel Tablets Drug Administration United States Food
Source: indiainfoline.com